Journal List > J Korean Med Assoc > v.46(7) > 1080269

Kim: Recent Advances in the Diagnosis and Treatment for Rectal Cancer

Abstract

Optimal surgical treatment of rectal cancer is important to control local disease and preserve voiding and sexual function with a good quality of life. Anal sphincter preservation is a challenging issue in distal rectal cancer. Preoperative combined multimodality treatment might increase the rate of anal sphincter preservation. Postoperative adjuvant therapy with chemoradiation in stage II and III seems to increase survical rates and decrease local failure. To achieve the best oncologic and functional outcomes, the extent and type of surgery must be chosen based upon accurate preoperative staging of rectal cancer. Early cancer can be managed with minimal invasive surgery, however, neoadjuvant chemoradiation therapy on patients with locally advanced rectal cancer can improve resectability and oncologic outcomes. The rate of local failure is markedly decreased with the development of sharp pelvic dissection and the concept of total mesorectal excision. Total mesorectal excision is to remove rectal cancer and surrounding mesorectum completely without interruption of the rectal proper fascia. Optimized surgical technique and adjuvant chemoradiation can guarantee a promising oncologic outcomes ; however, difficulties of management of patients with local or systemic failure still remain.

Figures and Tables

Figure 1
jkma-46-620-g001
Figure 2
jkma-46-620-g002
Figure 3
jkma-46-620-g003
Figure 4
jkma-46-620-g004
Table 1
jkma-46-620-i001
Table 2
jkma-46-620-i002
Table 3
jkma-46-620-i003

References

1. Kim NK, Choi JS, Sohn SK, Min JS. Transrectal ultrasonography in preoperative staging of rectal cancer. Yonsei Med J. 1994. 35:396–403.
crossref
3. Kim NK, Kim MJ, Park JK, Park SI, Min JS. Preoperative staging of rectal cancer with MRI : accuracy and clinical usefulness. Ann Surg Oncol. 2000. 7:732–737.
crossref
4. Kim NK, Kim MJ, SH Yun, Sohn SK, Min JS. Comparative study of transrectal ultrasonography, pelvic computerized tomography and magnetic resonance imaging in preoperative staging of rectal cancer. Dis Colon Rectum. 1999. 42:770–775.
crossref
5. Moriya Y, Hojo K, Sawada T, Koyama Y. Significance of lateral node dissection for advanced rectal cancer at or below the peritoneal reflection. Dis Colon Rectum. 1989. 32:307–315.
crossref
6. Moriya Y, Sugihara K, Akasu T, Fujita S. Importance of extended lymphadenectomy with lateral node dissection for advanced lower rectal cancer. World J Surg. 1997. 21:728–732.
crossref
7. Heald RJ, Morgan BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal Cancer : The Basingstoke experience of total mesorectal excision 1978-1997. Arch Surg. 1998. 133:894–899.
8. Enker WE. Total Mesorectal Excision-the New Golden standard of surgery for rectal cancer. Ann Med. 1997. 29:127–133.
crossref
9. Enker WE, Thaler HT, Cranor ML, Polyak T. Total Mesorectal Excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995. 181:335–346.
11. Lee W, Lee D, Choi S, Chun H. Transanal endoscopic microsurgery and radical surgery : T1 and T2 rectal cancer. Surg Endosc. 2003. 17:1283–1287.
crossref
12. Wong WD, Congliosi SM, Spencer MP, Corman ML, Tan P, Tsai JY. The safety and efficacy of the artificial bowel sphincter for fecal incontinence : results from a multicenter cohort study. Dis Colon Rectum. 2002. 45:1139–1153.
crossref
14. Kim NK, Lim DJ, Yun SH, Sohn SK, Min JS. Ultralow anterior resection and coloanal anastomosis for distal rectal cancer: fucntional and oncologic outcomes. Int J Colorectal Dis. 2001. 16:234–237.
crossref
15. Kim NK, Ahn TW, Park JK, Lee KY, Lee WH, Min JS, et al. Assessment of sexual and voiding function after total mesorectal excision with pelvic autonomic nerve preservation in male with rectal cancer. Dis Colon Rectum. 2002. 45:1178–1185.
crossref
16. Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van de Velde CJ, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer : an international analysis of 1411 patients. Eur J Surg Oncol. 1999. 25:368–374.
crossref
23. Kim NK, Min JS, Park JK, Yun SH, Seong JS, Roh JK, et al. Intravenous 5 fluorouracil versus oral doxifluridine as preoperative concurrent chemoradiation for locally advanced rectal cancer. Jpn J Clin Oncol. 2001. 31:25–29.
crossref
25. Minsky BD. Adjvuant therapy of resectable rectal cancer. Cancer treatment reviews. 2002. 28:181–188.
TOOLS
Similar articles